Corvus Pharma Com (CRVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 5,935 | 6,253 | 5,651 | 5,560 | 5,622 |
| Operating Income | -5,935 | -6,253 | -5,651 | -5,560 | -5,622 |
| Other Income | 1,673 | 552 | -1,002 | -440 | -881 |
| Pre-tax Income | -4,262 | -5,701 | -6,653 | -6,000 | -6,503 |
| Net Income Continuous | -4,262 | -5,701 | -6,653 | -6,000 | -6,503 |
| Net Income | $-4,262 | $-5,701 | $-6,653 | $-6,000 | $-6,503 |
| EPS Basic Total Ops | -0.07 | -0.12 | -0.13 | -0.12 | -0.14 |
| EPS Basic Continuous Ops | -0.07 | -0.12 | -0.13 | -0.12 | -0.14 |
| EPS Diluted Total Ops | -0.07 | -0.12 | -0.13 | -0.12 | -0.14 |
| EPS Diluted Continuous Ops | -0.07 | -0.12 | -0.13 | -0.12 | -0.14 |
| EPS Diluted Before Non-Recurring Items | -0.07 | -0.12 | -0.14 | N/A | N/A |
| EBITDA(a) | $-6,138 | $-6,381 | $-5,750 | $-5,775 | $-5,844 |